Home / Europe / Netherlands / Life Sciences & Healthcare

Life Sciences & Healthcare

Law Firm in the Netherlands specialised in Life Sciences & Healthcare

Our dedicated Life Sciences & Healthcare team specialises in advising clients in the pharmaceutical, medical devices, cosmetics, novel food and agriculture industry. ​

We have extensive experience in serving our clients, who represent 80% of the leading industry players. Because many of us have in-house experience, we understand your unique challenges and needs and have the ability to provide you with hands-on commercial advice.​

Our team operates across all relevant legal disciplines involved in supporting this sector. This includes industry specific regulatory and compliance work, intellectual property matters and competition law advice. We also advise on commercial, data privacy, employment, real estate and corporate matters. Our expertise allows us to meet both local and international business needs of our clients.

Their litigation abilities are excellent, with in-firm expertise available on related legal topics.

The Legal500 EMEA, 2022

Clients particularly value the team's commercial awareness, praising their "good insights into what is going on in the pharmaceutical market in the Netherlands."

Chambers Europe, 2022

The team is recommended for its "specific knowledge regarding tenders and projects in the field of medical appliances."

Chambers Europe 2021

The firm has "an excellent knowledge of pharmaceutical regulations and a practical mindset."

Chambers Europe 2021

‘Speedy responses and practical advice in pharma and corporate law matters.’

The Legal 500 EMEA, 2020

"really brilliant" , "broad network" and that the firm "co-ordinates things well".

Chambers Europe-wide, 2020

"Really efficient and quick."

Chambers Global, 2020

"The firm is a reliable international firm that has shown us a deep knowledge of the applicable law and significant practical experience on relevant cases."

Chambers Global, 2020

Choose area

E-Health
With technology and digital innovation at the forefront of many advancements in the life sciences industry and healthcare delivery, companies are cons
Medical Devices and Diagnostics
Medical devices and diagnostics are quickly evolving, integrating innovative tech solutions that use and generate increasing amounts of data. They hav
Novel Food (incl. Cannabis/CBD)
An ever increasing awareness of climate change and the need to modify our behaviour to address it, is leading to a huge demand for more sustainable &n
microscope with bottles of chemicals in forefront
Pharmaceuticals
In the last decade, it has become increasingly complex and costly to obtain marketing authorisation. On top of this,  market access has become &n
Subscribe to Life Sciences & Healthcare topics
Stay up-to-date with our client services.
03/01/2024
CMS Life Sciences & Healthcare Global Brochure
With big deals fuelling record levels of M&A activity, a steady stream of innovative and disruptive technologies, new and increasingly complex regulatory challenges and a thriving start-up community...

Feed

30/01/2024
What’s in a name? Updated EMA guideline on naming medicinal products processed...
The updated EMA Guideline on the acceptability of names for human medicinal products processed through the centralised procedure was adopted by CHMP in December 2023 and came into effect on 1 January...
08/01/2024
Adapting to the new EU Data Act: implications for medical devices and other...
In recent years, the European Commission developed a European data strategy, which aims to create a single European market in which data can circulate freely. As the European Commission has emphasized...
03/01/2024
CMS Life Sciences & Healthcare Global Brochure
With big deals fuelling record levels of M&A activity, a steady stream of innovative and disruptive technologies, new and increasingly complex regulatory challenges and a thriving start-up community...
18/12/2023
Digital health apps and telemedicine in the Netherlands
Digital Health Apps/Software 1. How is the software within digital health apps classified in your jurisdiction, and what regulation(s) apply? The relevant legislation is the “Wet op de medische hulpmiddelen...
Comparable
14/12/2023
ESG Power Hour: Discover the trends for 2024
We cordially invite you to the webinar "ESG Power Hour: Discover the Trends for 2024" on Thursday 14 December 2023, from 08:30 to 09:30 AM, live via GoTo Webinar.
08/12/2023
COP28: Global Health Under the Spotlight
Health took centre stage at the first ever ‘Health Day’ at COP28 on 3 December. The program focused the attention of world leaders on the profound public health-related issues stemming from climate...
08/11/2023
CMS Life Sciences Vital Signs, Winter 2023
2023 has seen some significant legal developments impacting the life sciences industry, and as we look ahead to 2024, there are several important developments which we would like to keep our clients informed...
08/11/2023
Cannabis law and legislation in the Netherlands
Medical use The Dutch Opium Act distinguishes drugs with a low risk of harm (‘soft drugs’) from drugs with a high risk of harm (‘hard drugs’). Cannabis is listed under the soft drugs category...
28/09/2023
EP Case Law in Brief: Erroneous Disclosures
“Mistakes in a document do not in themselves constitute prior art such as to prevent the grant of a patent.”So begins section I.C. 4.9 of the Case Law of the Boards of Appeal. This statement, and...
12/09/2023
CMS European Class Actions Report 2023
Data-driven insights into class action risk across Europe, a key concern for major corporates
15/08/2023
AI in healthcare inventions – technical or not technical?
SummaryRecent European Patent Office (EPO) Board of Appeal case T 1910/20 sits among a number of decisions regarding the discussion of what constitutes technical character in the field of healthcare...
28/06/2023
UK announces £21m AI roll-out across NHS
IntroductionOn 23 June 2023, the UK government announced a £21 million fund aimed at accelerating the deployment of Artificial Intelligence (“AI”) across the National Health Service (“NHS”)...